Literature DB >> 7841857

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.

J R Hughes1, S T Higgins, W K Bickel.   

Abstract

Many of the symptoms of nicotine withdrawal are similar to those of other drug withdrawal syndromes: anxiety, awakening during sleep, depression, difficulty concentrating, impatience, irritability/anger and restlessness. Slowing of the heart rate and weight gain are distinguishing features of tobacco withdrawal. Although nicotine withdrawal may not produce medical consequences, it lasts for several weeks and can be severe in some smokers. Like most other drug withdrawals, nicotine withdrawal is time-limited, occurs in non-humans, is influenced by instructions/expectancy and abates with replacement therapy and gradual reduction. Unlike some other drug withdrawal syndromes, protracted, neonatal or precipitated withdrawal does not occur. Whether nicotine withdrawal is associated with tolerance, acute physical dependence, greater duration and intensity of use, rapid reinstatement, symptom stages, cross-dependence with other nicotine ligands, reduction by non-pharmacological interventions and genetic influences is unclear. Whether nicotine withdrawal plays a major role in relapse to smoking has not been established but this is also true for other drug withdrawal syndromes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841857     DOI: 10.1111/j.1360-0443.1994.tb03744.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  94 in total

1.  Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving.

Authors:  Vincenzo Teneggi; Lisa Squassante; Laura Iavarone; Stefano Milleri; Alan Bye; Roberto Gomeni
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal.

Authors:  Robert West; Peter Hajek
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

3.  The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.

Authors:  Thomas J Gould; George S Portugal; Jessica M André; Matthew P Tadman; Michael J Marks; Justin W Kenney; Emre Yildirim; Michael Adoff
Journal:  Neuropharmacology       Date:  2012-01-21       Impact factor: 5.250

4.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

5.  Acute effects of self-paced walking on urges to smoke during temporary smoking abstinence.

Authors:  Adrian H Taylor; Magdalena Katomeri; Michael Ussher
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

6.  Short-term weight gain by menstrual phase following smoking cessation in women.

Authors:  Sharon S Allen; Alicia M Allen; Marc Mooney; Tracy Bade
Journal:  Eat Behav       Date:  2008-10-28

Review 7.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

Review 9.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

Review 10.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.